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ABSTRACT
Simple, low-cost and effective diagnostic tests for tuberculosis (TB) are needed especially 
in TB-high burden settings. The present study evaluated the performance of an in-house 
loop-mediated isothermal amplification (LAMP) for diagnosing TB by comparing it to 
Xpert MTB/RIF, microscopy and culture. In Thailand, a total of 204 excess sputum samples 
volume after the processing of cultures were used for Mycobacterium tuberculosis (MTB) 
detection by Xpert MTB/RIF and LAMP. Based on culture results as the gold standard, the 
overall sensitivity of LAMP and Xpert MTB/RIF were 82.1% (126/153; 95% confidential 
interval [CI]: 75.4-88.98%) and 86.9 % (133/153; 95% CI: 80.5-90.8%) respectively, and 
the specificity of both tests was 100% (51/51; 95% CI: 93.0-100.0%). In comparison with 
Xpert MTB/RIF, the sensitivity and specificity of LAMP were 94.7% (126/133; 95% 
CI: 89.5-97.9%), and 100.0% (73/73; 95% CI: 94.9-100.0%), respectively. The average 
threshold cycle (Ct) of Xpert MTB/RIF detection for positive and negative LAMP results 
was statistically different, of 18.4 and 27.0, respectively (p < 0.05). In comparison with the 
acid-fast staining technique, and analyzing LAMP and Xpert MTB/RIF in smear-negative/
culture-positive specimens, there was an increase of the detection rate by 47.7% (21/44) and 
54.6% (24/44). The diagnostic sensitivity and specificity of LAMP appeared to be comparable 
to those of Xpert MTB/RIF. We claim that this LAMP has potential to provide a sensitive 
diagnostic test for the rapid TB diagnosis. It allowed a fast detection of MTB before the 
cultures and it could be used in resource-limited laboratory settings.
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INTRODUCTION
Tuberculosis (TB) remains a global health problem. Recently, in 2018, there 
were an estimated 10 million new TB cases and 1.4 million deaths worldwide1. 
Rapid and accurate diagnostic tests are required to notify TB cases. Even though 
microscopy for acid-fast bacilli is easy, fast and inexpensive to perform, this method 
has a low sensitivity and cannot distinguish between Mycobacterium tuberculosis 
(MTB) and non-tuberculous mycobacteria (NTM)2. For this reason, several tools 
based on molecular techniques to detect MTB nucleic acids directly from clinical 
specimens were developed. In 2010, the World Health Organization (WHO) 
endorsed Xpert MTB/RIF (Cepheid, Sunnyvale, CA, USA), an automated real-
time PCR3,4. This molecular technique can simultaneously detect MTB DNA and 
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the resistance to rifampicin, the most effective drug used 
for TB therapy, based on the detection of the rpoB gene 
and its mutations, which confer resistance to rifampicin. 
GeneXpert machines and cartridges have been distributed 
and available in many regions in both, high and low-income 
countries. It has rapidly become widespread as a molecular 
point-of-care test (POCT) and provided a new approach 
for the rapid TB diagnosis. However, the economical 
technique is still required in many resource-limited 
countries with a high-TB burden like Thailand, and others, 
since GeneXpert instruments require high maintenance 
service charges and cartridges are expensive for low-
income areas. A quite effective, but inexpensive screening 
test for MTB detection might reduce the costs from using 
Xpert MTB/RIF tests in many TB cases. Loop-mediated 
isothermal amplification (LAMP), a novel nucleic acid 
amplification test was developed5,6 and has several 
advantages for the rapid MTB detection. It provides a highly 
sensitive and specific detection at low costs and no need 
of sophisticated machines. A commercial product to detect 
MTB based on the LAMP technique has been developed 
by Eiken Chemical Company (Tokyo, Japan)7 and now 
is available in more countries. Previously, Pandey et al.8 
proposed the use of an in-house LAMP to detect MTB 
directly from processed sputum samples. In comparison 
with a gold standard culture technique, this in-house LAMP 
showed high sensitivity (100.0%) and specificity (94.2%). 
This could be applied for the rapid confirmation of MTB 
growth in culture media and we reported its high sensitivity 
and specificity9. However, the diagnostic performance data 
of this in-house LAMP in this setting is limited. Here, we 
evaluated the performance of an in-house LAMP for the 
rapid detection of MTB in processed sputum samples by 
comparing it to Xpert MTB/RIF and mycobacterial culture. 
The study was carried out in Thailand, a TB-endemic 
setting, where the use of a LAMP technique would be 
appropriate.
MATERIALS AND METHODS
Clinical specimens and sample processing
This study was approved by the Ethics Committee of 
Mae Sot Hospital. From April to September 2018, sputum 
specimens were consecutively obtained from patients with 
symptoms compatible with TB. The clinical specimens were 
processed according to the routine mycobacteria laboratory 
procedure at Mae Sot Hospital, Tak province. After receipt, 
sputum samples were checked and decontaminated using 
the sodium hydroxide-N-acetyl-L-cysteine (NaOH-NALC) 
method10. Briefly, an equal volume of the decontamination 
solution together with digestion agents were added to each 
sputum sample in a 50-mL centrifuge tube. After remaining 
at room temperature for 15 min, the mixture was vortexed and 
subsequently neutralized with a phosphate-buffered saline 
(PBS; pH 6.8). Then, the mixture was centrifuged at 3,000 × g 
for 15 min at 4 °C and the supernatant was discarded. The 
pellets were resuspended using 2 mL of PBS. The bacterial 
culture was then conducted in both, solid (Löwenstein–Jensen; 
LJ) and liquid medium (Mycobacteria Growth Indicator 
Tube; MGIT; Becton Dickinson, San Diego, CA, USA) by 
inoculating ~100 µL and 500 µL of the cell suspension to 
LJ and MGIT culture media, respectively. Mycobacterial 
growth was observed periodically. Microscopic examination 
for acid-fast bacilli (AFB) was performed in positive cultures 
and the growth of bacteria was confirmed for MTB by a rapid 
immunochromatographic identification test (SD BIOLINE 
TB Ag MPT64 Rapid kit; Standard Diagnostics, Korea) 
according to the manufacturer’s instruction. Cultures that 
showed contamination were repeated and excluded from 
further analysis. 
DNA extraction
DNA was extracted using the FlexiGene DNA Kit 
(Qiagen, Hilden, Germany) with modifications. Briefly, 
500 µL of the remaining cell suspension from the process 
of mycobacterial culture were used. After centrifugation, 
the sediment was added to 50 µL of buffer FG2/QIAGEN 
protease and vortexed immediately until the pellet was 
completely homogenized. The mixture was placed in a 
heating block or water bath and incubated at 65 °C for 
10 min, and then at 95 °C for 10 min to stop the enzymatic 
activity. Fifty microliters of isopropanol (100%) were 
added and mixed thoroughly by inversion. Centrifugation 
at 13,000 × g for 5 min was performed and the supernatant 
was subsequently decanted. After another centrifugation at 
13,000 × g for 5 min followed by discarding the supernatant, 
DNA was recovered. The sample was air-dried for at least 
5 min. Finally, 30 µLof sterile distilled water were added 
to re-suspend the DNA. The resulting DNA was kept at 
-20 °C for further experiments.
In-house loop-mediated isothermal amplification 
assay
A set of LAMP primers, the reaction mixture, and the 
amplification conditions were as described previously8,9,11. 
Briefly, LAMP reactions were performed in a total volume 
of 20 µL consisting of 30 pmol of each of the inner primers 
(FIP and BIP), 5 pmol each of the outer primers (F3 and B3), 
20 pmol each of the loop primers (FLP and BLP), 1.4 mM 
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deoxynucleoside triphosphate, 0.8 M betaine, 20 mM Tris-






, 8 mM MgSO
4
, 
8 U Bst DNA polymerase (New England Biolabs, Ipswich, 
MA, USA) and 1 µL of the fluorescent detection reagent 
(FDR; Eiken Chemical, Tokyo, Japan) with 6 µL of extracted 
DNA. Amplification was performed at 65 °C for 60 min in 
a water bath. Each run contained a positive purified MTB 
H37Ra DNA (0.1 ng/mL) control and a negative control 
(distilled water). LAMP results were examined directly by 
visual observation. The result was considered positive when 
the color turned from orange to green. For the amplicon 
confirmation, 5 µL of the LAMP reaction product were 
analyzed by electrophoresis on 2% agarose gels. 
Xpert MTB/RIF assay
The Xpert MTB/RIF assay was performed according 
to the manufacturer’s protocol. Briefly, 500 µL of cell 
suspension were mixed with 1.5 mL of the sample reagent 
from the test kit. After being vortexed and standing for 
15 min, 2 mL of the mixture were transferred into the 
Xpert MTB/RIF cartridge which then inserted in the 
module of the GeneXpert machine. The system operated 
automatically and interpreted the result of the MTB 
detection and the resistance to rifampicin by measuring 
the fluorescent signals. The threshold cycle (Ct) of the 
Xpert MTB/RIF detection in each sample was recorded 
and analyzed. Invalid results were excluded from further 
analysis.
Statistical analysis
Determination of sensitivity, specificity with 95% 
confidential interval (CI) and comparison of means were 
performed using the Student’s t-test (SAS® University 
Edition12,13). P-values less than 0.05 were considered 
statistically significant.
RESULTS
Acid-fast staining and MTB culturing results of clinical 
specimens
After exclusion of culture contamination and Xpert 
MTB/RIF invalid results, a total of 204 processed sputum 
specimens were obtained and analyzed. Of these, 109 were 
AFB-positive and 95 were AFB-negative by the microscopy 
of smears. All AFB-positive samples were positive by 
culture and identified as MTB. For AFB-negative samples, 
44 were confirmed as MTB by culture and the other 51 were 
culture-negative.
Performance of in-house LAMP and Xpert MTB/RIF 
for MTB detection comparing to acid-fast staining and 
MTB culturing
All samples were subjected to LAMP and Xpert MTB/
RIF analyses. Of the 204 samples tested, 121 were LAMP 
positive (color change from orange to bright green) and two 
were considered positive after the analysis on agarose gels. 
(given the MTB-positive pattern; Figure 1). Twenty-seven 
samples were negative by LAMP. For Xpert MTB/RIF, 133 
from the 204 samples were considered MTB detected and 
the others were MTB not detected. The overall sensitivity 
and specificity of LAMP when compared to MTB culture 
were 82.4% (95% confidential interval [CI]: 75.4-88.0%) 
and 100.0% (95% CI: 93.0-100.0%), respectively. When 
compared with MTB culture, Xpert MTB/RIF showed 
86.9% of sensitivity (95% CI: 80.5-91.8%) and 100.0% 
of specificity (95% CI: 93.0-100.0%). Sensitivities of 
in-house LAMP and Xpert MTB/RIF were 96.3% (105/109) 
and 100.0% (109/109) in smear-positive/culture-positive 
specimens, and 47.7% (21/44) and 54.6% (24/44) in smear-
negative/culture-positive specimens. The summary data of 
the sensitivity analyses were shown in Table 1.
Comparison of in-house LAMP and Xpert MTB/RIF 
for MTB detection
For the MTB detection, LAMP showed an overall 
sensitivity and specificity of 94.7% (95% CI: 89.5 to 97.9) 
and 100.0% (95% CI: 94.9 to 100.0), respectively, when 
Figure 1 - Gel electrophoresis pattern of the in-house LAMP 
assay (lane 1- 1 kb DNA ladder; lane 2- positive control; lane 
3-4: negative sample by color change, but positive by gel 
electrophoresis; lane 5; negative sample by color change and 
gel electrophoresis; and lane 6- negative control).
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compared to Xpert MTB/RIF (Table 2). Seven negative 
cases by LAMP, but positive by Xpert MTB/RIF showed 
an average threshold cycle (Ct) of 27.0, while an average 
of the Ct from the other 126 positive samples was 18.4. 
Comparing the average Ct detected by Xpert MTB/RIF 
between groups of LAMP-positive and LAMP-negative, 
a statistically significant difference (p < 0.05) was found 
(Figure 2).
DISCUSSION
Detection of MTB directly from clinical specimens is 
a crucial part of TB diagnosis because it helps clinicians 
to ensure the clinical diagnosis and to reduce the waiting 
time for the bacterial culture. Acid-fast microscopy remains 
the main tool for pulmonary tuberculosis diagnosis since 
it is readily available, rapid and inexpensive. Molecular 
assays are now selected and used to replace or to be used 
in combination with the acid-fast staining which exhibits 
a low sensitivity. In smear-negative cases, the molecular 
tests have been showing to improve the diagnosis of TB and 
decrease the time to initiate TB treatment. Xpert MTB/RIF 
and LAMP are molecular techniques that were recommended 
by WHO. Because Xpert MTB/RIF is automated, it allows 
the analysis to be performed in clinics or microscopic centers 
and it is now widely used in many countries. In contrast, 
LAMP is a manual cost effective molecular technique 
proposed to provide an accurate and convenient alternative 
for TB diagnosis in resource-constrained settings. In the 
present study, we reported the promising performance of an 
in-house LAMP targeting MTB 16S rRNA gene to detect 
MTB from sputum specimens in comparison with the results 
of microscopy, culture and Xpert MTB/RIF. The overall 
sensitivity of the in-house LAMP was 82.4% when compared 
to the culture, which was lower than in a previous report8 and 
slightly lower than the 84.4% of a commercial LAMP used in 
a multicenter study14. However, a recent study in Uganda and 
Vietnam showed that the sensitivity of a commercial LAMP 
was only 55.4 and 45.5%, respectively15,16. The data from a 
systematic review and meta-analysis, in 2016, showed that 
any LAMP assays including both commercially available 
and an in-house, reached sensitivities around 90%17. Indeed, 
the results of the studies on the performance of techniques 
can vary greatly according to the prevalence of TB and to 
the studied populations. Besides differences among LAMP 
Table 1 - Comparison of an in-house LAMP and the Xpert MTB/RIF results with MTB cultures
Test  
MTB culture




82.4 (75.4 to 88.0) 100.0 (93.0 to 100.0)
Negative 272 51
Xpert MTB/RIF
MTB detected 1333 0
86.9 (80.5 to 91.8) 100.0 (93.0 to 100.0)
MTB not detected 204 51
1105 were AFB-positive and 21 were negative; 24 were AFB-positive and 23 were negative; 3109 were AFB-positive and 24 were 
negative; 420 were AFB-negative. MTB = Mycobacterium tuberculosis; LAMP = loop-mediated isothermal amplification; CI = 
confidential interval
Table 2 - Comparison of in-house LAMP result with Xpert MTB/RIF
Test Result 
Xpert MTB/RIF






94.7 (89.5 to 97.9) 100.0 (94.9 to 100.0)
Negative 7 71
MTB = Mycobacterium tuberculosis; LAMP = loop-mediated isothermal amplification; CI = confidential interval
Figure 2 - Distribution of the average Ct values of Xpert MTB/
RIF with respect to the in-house LAMP results. Median of 
average Ct values for LAMP-positive samples (n = 126) and 
negative samples (n = 7) were 17.9 and 29.8, respectively 
(p < 0.05). LAMP, loop-mediated isothermal amplification.
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protocols, specimen types (direct or processed sputum) and 
DNA extraction protocols were also the main points resulting 
in variable values of diagnostic sensitivity among studies. 
When compared to Xpert MTB/RIF alone, the in-house 
LAMP showed great sensitivity and specificity, of 94.7% 
and 100.0%, respectively. Several studies reported that 
LAMP and Xpert MTB/RIF had comparably high levels of 
sensitivity and specificity for the diagnosis of TB18-20. In this 
comparison, we showed similar sensitivity and specificity of 
the in-house LAMP and Xpert MTB/RIF. When culture was 
considered as the gold standard, the sensitivity of LAMP and 
Xpert were 82.1% and 86.9%, respectively, and the specificity 
of both tests was 100%. Therefore, the performance of the in-
house LAMP was promising. This study has also determined 
the threshold cycle (Ct) of Xpert MTB/RIF detection in 
LAMP-positive and LAMP-negative groups. The average Ct 
value in seven false-negative samples of the in-house LAMP 
was higher (27.0) compared to that of 18.4 in true-positive 
cases and the difference was statistically significant. The 
false-negative results of LAMP in AFB-negative samples 
might be attributed to the limit of detection of the test. Using 
culture as the gold standard, the false-negative results were 
found in 27 samples of the in-house LAMP and in 20 samples 
of Xpert MTB/RIF which might have occurred because of 
the lower limit of detection of LAMP and Xpert MTB/RIF 
compared to that of culture, as described elsewhere3,8,21.
The LAMP assay showed a high sensitivity and 
specificity. The method has other advantages such as 
easy detection, speed, safety and low cost. Even having 
several advantages, this simple technique has some 
disadvantages. Firstly, it is not automated, all the processes 
(DNA extraction, amplification, and result interpretation) 
are manual. Secondly, the evaluation in a clinical setting 
is still limited. Importantly, a major weakness of LAMP 
compared to Xpert MTB/RIF is that it cannot determine 
the resistance to rifampicin, hence the use of LAMP in a 
high rifampicin-resistant burden area is not recommended. 
In addition, the cost-effectiveness between these two 
molecular assays also needs to be investigated. Furthermore, 
the colorimetric determination of the LAMP reaction was 
easy but might be subjective when determined by visual 
observation alone22, as we found two samples that were 
negative by visual observation but were positive by agarose 
gel electrophoresis. However, in general, theses aspects 
may not be restrictive for the use of LAMP in the rapid 
TB diagnosis.
One limitation of our study was that the specimens 
used for DNA extraction and the in-house LAMP and 
Xpert MTB/RIF analysis were remaining sediments from 
the decontamination process of the mycobacterial culture. 
By this approach, we could compare the molecular results 
with those of culture which remains the gold standard 
for MTB diagnosis. We introduced the in-house LAMP 
into the routine practice by using remaining samples. In 
general, the diagnosis of TB in the hospital is mainly based 
on smear microscopy, X-ray, and culture confirmation. 
Xpert MTB/RIF has been recently incorporated into the 
routine procedures of TB testing in Thailand. However, 
all specimens cannot be tested by Xpert MTB/RIF due 
to the high number of cases versus the high cost and the 
limited supply of cartridges. Also, Xpert MTB/RIF is 
available only in large hospitals and medical centers or 
reference laboratories but not in district hospitals. LAMP 
is an affordable assay for low resource-settings without the 
need of expensive instruments. Our in-house LAMP can 
be performed at a much lower cost, around US$ 1-2, an 
amount that is similar to the one from a previous report23, 
and compared to the US$ 9.98 negotiated prices of the 
Xpert MTB/RIF24. In addition, several samples could be 
handled at the same time and it could provide a shorter 
turnaround time to results, within 2-3 h. It can be used in 
hospitals and it is also suitable for use in mycobacterial 
culture centers in which it would allow the rapid detection 
of MTB before bacterial cultures. In conclusion, the 
performance of this in-house LAMP showed a high 
sensitivity and specificity for rapid MTB detection when 
compared to culture and Xpert MTB/RIF. It has potential 
to be provided a rapid, early diagnosis of TB and can be 
useful for the effective patient management.
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